Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (191-200 of 365) with videos related to

Pageof 37
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 2, 2019
Diagnosis of hepatitis C virus infection in Spain: An opportunity to improveJavier Crespo, Pablo Lázaro de Mercado, Antonio Javier Blasco Bravo, et al.
International Journal of Molecular Sciences|May 13, 2023
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive ReviewAitor Odriozola, Alvaro Santos-Laso, María Del Barrio, et al.
Hepatology International|September 13, 2018
Metabolic effects of reduced growth hormone action in fatty liver diseaseKerstin Rufinatscha, Claudia Ress, Sabrina Folie, et al.
Hepatology (Baltimore, Md.)|August 21, 2024
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver diseaseDana Ivancovsky Wajcman, Christopher J Byrne, John F Dillon, et al.
International Journal of Molecular Sciences|December 16, 2020
Congestive HepatopathyJosé Ignacio Fortea, Ángela Puente, Antonio Cuadrado, et al.
Medicina Clinica|February 5, 2017
Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health SystemMaría Buti, Jose Luis Calleja, Javier García-Samaniego, et al.
BMC Public Health|December 5, 2023
The Cantabria Cohort, a protocol for a population-based cohort in northern SpainMarta Alonso-Peña, Trinidad Dierssen, Maria José Marin, et al.
Schizophrenia Research|June 13, 2022
Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective studySara Galiano Rus, Víctor Ortiz García de la Foz, María Teresa Arias-Loste, et al.
Journal of Hepatology|October 5, 2014
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisMaria-Carlota Londoño, Christie Perelló, Joaquín Cabezas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2010
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentrationMónica Guevara, María E Baccaro, Jose Ríos, et al.
Pageof 37

Showing results (191-200 of 365) with videos related to

Sort By:
Pageof 37
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 2, 2019
Diagnosis of hepatitis C virus infection in Spain: An opportunity to improveJavier Crespo, Pablo Lázaro de Mercado, Antonio Javier Blasco Bravo, et al.
International Journal of Molecular Sciences|May 13, 2023
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive ReviewAitor Odriozola, Alvaro Santos-Laso, María Del Barrio, et al.
Hepatology International|September 13, 2018
Metabolic effects of reduced growth hormone action in fatty liver diseaseKerstin Rufinatscha, Claudia Ress, Sabrina Folie, et al.
Hepatology (Baltimore, Md.)|August 21, 2024
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver diseaseDana Ivancovsky Wajcman, Christopher J Byrne, John F Dillon, et al.
International Journal of Molecular Sciences|December 16, 2020
Congestive HepatopathyJosé Ignacio Fortea, Ángela Puente, Antonio Cuadrado, et al.
Medicina Clinica|February 5, 2017
Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health SystemMaría Buti, Jose Luis Calleja, Javier García-Samaniego, et al.
BMC Public Health|December 5, 2023
The Cantabria Cohort, a protocol for a population-based cohort in northern SpainMarta Alonso-Peña, Trinidad Dierssen, Maria José Marin, et al.
Schizophrenia Research|June 13, 2022
Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective studySara Galiano Rus, Víctor Ortiz García de la Foz, María Teresa Arias-Loste, et al.
Journal of Hepatology|October 5, 2014
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosisMaria-Carlota Londoño, Christie Perelló, Joaquín Cabezas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2010
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentrationMónica Guevara, María E Baccaro, Jose Ríos, et al.
Pageof 37